Loading…
FUNCTIONAL PARTIAL AGONISM AT IONOTROPIC EXCITATORY AMINO ACID RECEPTORS
( RS)-2-Amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid (APPA), which is an analogue of ( RS)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA), shows the characteristics of a partial AMPA receptor agonist. Since ( S)-APPA is a full AMPA agonist and ( R)-APPA a competitive ant...
Saved in:
Published in: | Neurochemistry international 1996-09, Vol.29 (3), p.309-316 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c386t-8cb86873ba64ba1b5c5c23cee1adc119bf5a1ce936658700a0f94923b05caf8f3 |
---|---|
cites | |
container_end_page | 316 |
container_issue | 3 |
container_start_page | 309 |
container_title | Neurochemistry international |
container_volume | 29 |
creator | EBERT, BJARKE MADSEN, ULF SØBY, KARINA K. KROGSGAARD-LARSEN, POVL |
description | (
RS)-2-Amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid (APPA), which is an analogue of (
RS)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA), shows the characteristics of a partial AMPA receptor agonist. Since (
S)-APPA is a full AMPA agonist and (
R)-APPA a competitive antagonist, the partial agonism observed for APPA, which is a 1:1 mixture of (
S)- and (
R)-APPA, is only apparent. These observations have prompted comparative pharmacological studies of different molar ratios of a series of AMPA and
N-methyl-
d
-aspartic acid (NMDA) agonists and respective competitive antagonists, and of these agonists in the presence of fixed concentrations of antagonist. Using the rat cortical wedge preparation, the latter series of experiments showed the expected rightward parallel shifts of the dose-response curves. The former type of experiments, on the other hand, produced dose-response curves at different levels of maximal response, depending on the molar ratios of agonist and antagonist used. This phenomenon, which is in agreement with the theory for competitive receptor interaction, has been termed
functional partial agonism, a new pharmacological concept of potential therapeutic utility. These results were obtained using AMPA, the AMPA agonist (
RS)-2-amino-3-(5-
tert-butyl-3-hydroxy-4-isoxazolyl)propionic acid (ATPA), the competitive AMPA antagonists (
RS-2-amino-3-(3-carboxymethoxy-5-methyl-4-isoxazolyl)propionic acid (AMOA) and 6-nitro-7-sulfamoylbenzo[
f] quinoxalin-2,3-dione (NBQX), NMDA, and the competitive NMDA antagonist (
RS)-3-(2-carboxy-4-piperazinyl)propyl-1-phosphonic acid (CPP). Copyright © 1996 Elsevier Science Ltd. |
doi_str_mv | 10.1016/0197-0186(95)00151-4 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_78468358</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>0197018695001514</els_id><sourcerecordid>78468358</sourcerecordid><originalsourceid>FETCH-LOGICAL-c386t-8cb86873ba64ba1b5c5c23cee1adc119bf5a1ce936658700a0f94923b05caf8f3</originalsourceid><addsrcrecordid>eNp9kNFKwzAUhoMoc07fQKEXInpRTdomTW6EUrutsLWj60CvQpqmUOnW2WyCb2_myi69OnD-7_wcPgBuEXxGEJEXiJhvQ0TJI8NPECKMbO8MDBH1HZv52DsHwxNyCa60_oQQ-gziARhQSrHD4BBMx6skzOM0CWbWIsjy2Mxgkibxcm4FuWWCNM_SRRxa0XsY50GeZh9WMI-T1ArC-M3KojBamOXyGlxUotHqpp8jsBpHeTi1Z-kkDoOZLV1KdjaVBSXUdwtBvEKgAkssHVcqhUQpEWJFhQWSirmEYOpDKGDFPOa4BcRSVLRyR-Dh2Lvt2q-90ju-rrVUTSM2qt1r7lOPUBdTA3pHUHat1p2q-Lar16L74Qjyg0B-sMMPdjjD_E8g98zZXd-_L9aqPB31xkx-3-dCS9FUndjIWp8wFxFqqgz2esSUcfFdq45rWauNVGXdKbnjZVv__8cvQnWFGQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>78468358</pqid></control><display><type>article</type><title>FUNCTIONAL PARTIAL AGONISM AT IONOTROPIC EXCITATORY AMINO ACID RECEPTORS</title><source>ScienceDirect Freedom Collection</source><creator>EBERT, BJARKE ; MADSEN, ULF ; SØBY, KARINA K. ; KROGSGAARD-LARSEN, POVL</creator><creatorcontrib>EBERT, BJARKE ; MADSEN, ULF ; SØBY, KARINA K. ; KROGSGAARD-LARSEN, POVL</creatorcontrib><description>(
RS)-2-Amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid (APPA), which is an analogue of (
RS)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA), shows the characteristics of a partial AMPA receptor agonist. Since (
S)-APPA is a full AMPA agonist and (
R)-APPA a competitive antagonist, the partial agonism observed for APPA, which is a 1:1 mixture of (
S)- and (
R)-APPA, is only apparent. These observations have prompted comparative pharmacological studies of different molar ratios of a series of AMPA and
N-methyl-
d
-aspartic acid (NMDA) agonists and respective competitive antagonists, and of these agonists in the presence of fixed concentrations of antagonist. Using the rat cortical wedge preparation, the latter series of experiments showed the expected rightward parallel shifts of the dose-response curves. The former type of experiments, on the other hand, produced dose-response curves at different levels of maximal response, depending on the molar ratios of agonist and antagonist used. This phenomenon, which is in agreement with the theory for competitive receptor interaction, has been termed
functional partial agonism, a new pharmacological concept of potential therapeutic utility. These results were obtained using AMPA, the AMPA agonist (
RS)-2-amino-3-(5-
tert-butyl-3-hydroxy-4-isoxazolyl)propionic acid (ATPA), the competitive AMPA antagonists (
RS-2-amino-3-(3-carboxymethoxy-5-methyl-4-isoxazolyl)propionic acid (AMOA) and 6-nitro-7-sulfamoylbenzo[
f] quinoxalin-2,3-dione (NBQX), NMDA, and the competitive NMDA antagonist (
RS)-3-(2-carboxy-4-piperazinyl)propyl-1-phosphonic acid (CPP). Copyright © 1996 Elsevier Science Ltd.</description><identifier>ISSN: 0197-0186</identifier><identifier>EISSN: 1872-9754</identifier><identifier>DOI: 10.1016/0197-0186(95)00151-4</identifier><identifier>PMID: 8885290</identifier><identifier>CODEN: NEUIDS</identifier><language>eng</language><publisher>Oxford: Elsevier Ltd</publisher><subject>Alanine - analogs & derivatives ; Alanine - pharmacology ; Aminoacid receptors (glycine, glutamate, gaba) ; Animals ; Binding, Competitive - drug effects ; Biological and medical sciences ; Cell receptors ; Cell structures and functions ; Cerebral Cortex - drug effects ; Cerebral Cortex - metabolism ; Dinucleoside Phosphates - pharmacology ; Excitatory Amino Acid Agonists - pharmacology ; Excitatory Amino Acid Antagonists - pharmacology ; Fundamental and applied biological sciences. Psychology ; In Vitro Techniques ; Isoxazoles - pharmacology ; Models, Neurological ; Molecular and cellular biology ; N-Methylaspartate - pharmacology ; Propionates - pharmacology ; Quinoxalines - pharmacology ; Rats ; Receptors, AMPA - agonists ; Receptors, Glutamate - drug effects ; Receptors, Glutamate - metabolism</subject><ispartof>Neurochemistry international, 1996-09, Vol.29 (3), p.309-316</ispartof><rights>1996 Elsevier Science Ltd</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c386t-8cb86873ba64ba1b5c5c23cee1adc119bf5a1ce936658700a0f94923b05caf8f3</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=3168001$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/8885290$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>EBERT, BJARKE</creatorcontrib><creatorcontrib>MADSEN, ULF</creatorcontrib><creatorcontrib>SØBY, KARINA K.</creatorcontrib><creatorcontrib>KROGSGAARD-LARSEN, POVL</creatorcontrib><title>FUNCTIONAL PARTIAL AGONISM AT IONOTROPIC EXCITATORY AMINO ACID RECEPTORS</title><title>Neurochemistry international</title><addtitle>Neurochem Int</addtitle><description>(
RS)-2-Amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid (APPA), which is an analogue of (
RS)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA), shows the characteristics of a partial AMPA receptor agonist. Since (
S)-APPA is a full AMPA agonist and (
R)-APPA a competitive antagonist, the partial agonism observed for APPA, which is a 1:1 mixture of (
S)- and (
R)-APPA, is only apparent. These observations have prompted comparative pharmacological studies of different molar ratios of a series of AMPA and
N-methyl-
d
-aspartic acid (NMDA) agonists and respective competitive antagonists, and of these agonists in the presence of fixed concentrations of antagonist. Using the rat cortical wedge preparation, the latter series of experiments showed the expected rightward parallel shifts of the dose-response curves. The former type of experiments, on the other hand, produced dose-response curves at different levels of maximal response, depending on the molar ratios of agonist and antagonist used. This phenomenon, which is in agreement with the theory for competitive receptor interaction, has been termed
functional partial agonism, a new pharmacological concept of potential therapeutic utility. These results were obtained using AMPA, the AMPA agonist (
RS)-2-amino-3-(5-
tert-butyl-3-hydroxy-4-isoxazolyl)propionic acid (ATPA), the competitive AMPA antagonists (
RS-2-amino-3-(3-carboxymethoxy-5-methyl-4-isoxazolyl)propionic acid (AMOA) and 6-nitro-7-sulfamoylbenzo[
f] quinoxalin-2,3-dione (NBQX), NMDA, and the competitive NMDA antagonist (
RS)-3-(2-carboxy-4-piperazinyl)propyl-1-phosphonic acid (CPP). Copyright © 1996 Elsevier Science Ltd.</description><subject>Alanine - analogs & derivatives</subject><subject>Alanine - pharmacology</subject><subject>Aminoacid receptors (glycine, glutamate, gaba)</subject><subject>Animals</subject><subject>Binding, Competitive - drug effects</subject><subject>Biological and medical sciences</subject><subject>Cell receptors</subject><subject>Cell structures and functions</subject><subject>Cerebral Cortex - drug effects</subject><subject>Cerebral Cortex - metabolism</subject><subject>Dinucleoside Phosphates - pharmacology</subject><subject>Excitatory Amino Acid Agonists - pharmacology</subject><subject>Excitatory Amino Acid Antagonists - pharmacology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>In Vitro Techniques</subject><subject>Isoxazoles - pharmacology</subject><subject>Models, Neurological</subject><subject>Molecular and cellular biology</subject><subject>N-Methylaspartate - pharmacology</subject><subject>Propionates - pharmacology</subject><subject>Quinoxalines - pharmacology</subject><subject>Rats</subject><subject>Receptors, AMPA - agonists</subject><subject>Receptors, Glutamate - drug effects</subject><subject>Receptors, Glutamate - metabolism</subject><issn>0197-0186</issn><issn>1872-9754</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><recordid>eNp9kNFKwzAUhoMoc07fQKEXInpRTdomTW6EUrutsLWj60CvQpqmUOnW2WyCb2_myi69OnD-7_wcPgBuEXxGEJEXiJhvQ0TJI8NPECKMbO8MDBH1HZv52DsHwxNyCa60_oQQ-gziARhQSrHD4BBMx6skzOM0CWbWIsjy2Mxgkibxcm4FuWWCNM_SRRxa0XsY50GeZh9WMI-T1ArC-M3KojBamOXyGlxUotHqpp8jsBpHeTi1Z-kkDoOZLV1KdjaVBSXUdwtBvEKgAkssHVcqhUQpEWJFhQWSirmEYOpDKGDFPOa4BcRSVLRyR-Dh2Lvt2q-90ju-rrVUTSM2qt1r7lOPUBdTA3pHUHat1p2q-Lar16L74Qjyg0B-sMMPdjjD_E8g98zZXd-_L9aqPB31xkx-3-dCS9FUndjIWp8wFxFqqgz2esSUcfFdq45rWauNVGXdKbnjZVv__8cvQnWFGQ</recordid><startdate>19960901</startdate><enddate>19960901</enddate><creator>EBERT, BJARKE</creator><creator>MADSEN, ULF</creator><creator>SØBY, KARINA K.</creator><creator>KROGSGAARD-LARSEN, POVL</creator><general>Elsevier Ltd</general><general>Elsevier</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>19960901</creationdate><title>FUNCTIONAL PARTIAL AGONISM AT IONOTROPIC EXCITATORY AMINO ACID RECEPTORS</title><author>EBERT, BJARKE ; MADSEN, ULF ; SØBY, KARINA K. ; KROGSGAARD-LARSEN, POVL</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c386t-8cb86873ba64ba1b5c5c23cee1adc119bf5a1ce936658700a0f94923b05caf8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Alanine - analogs & derivatives</topic><topic>Alanine - pharmacology</topic><topic>Aminoacid receptors (glycine, glutamate, gaba)</topic><topic>Animals</topic><topic>Binding, Competitive - drug effects</topic><topic>Biological and medical sciences</topic><topic>Cell receptors</topic><topic>Cell structures and functions</topic><topic>Cerebral Cortex - drug effects</topic><topic>Cerebral Cortex - metabolism</topic><topic>Dinucleoside Phosphates - pharmacology</topic><topic>Excitatory Amino Acid Agonists - pharmacology</topic><topic>Excitatory Amino Acid Antagonists - pharmacology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>In Vitro Techniques</topic><topic>Isoxazoles - pharmacology</topic><topic>Models, Neurological</topic><topic>Molecular and cellular biology</topic><topic>N-Methylaspartate - pharmacology</topic><topic>Propionates - pharmacology</topic><topic>Quinoxalines - pharmacology</topic><topic>Rats</topic><topic>Receptors, AMPA - agonists</topic><topic>Receptors, Glutamate - drug effects</topic><topic>Receptors, Glutamate - metabolism</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>EBERT, BJARKE</creatorcontrib><creatorcontrib>MADSEN, ULF</creatorcontrib><creatorcontrib>SØBY, KARINA K.</creatorcontrib><creatorcontrib>KROGSGAARD-LARSEN, POVL</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neurochemistry international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>EBERT, BJARKE</au><au>MADSEN, ULF</au><au>SØBY, KARINA K.</au><au>KROGSGAARD-LARSEN, POVL</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>FUNCTIONAL PARTIAL AGONISM AT IONOTROPIC EXCITATORY AMINO ACID RECEPTORS</atitle><jtitle>Neurochemistry international</jtitle><addtitle>Neurochem Int</addtitle><date>1996-09-01</date><risdate>1996</risdate><volume>29</volume><issue>3</issue><spage>309</spage><epage>316</epage><pages>309-316</pages><issn>0197-0186</issn><eissn>1872-9754</eissn><coden>NEUIDS</coden><abstract>(
RS)-2-Amino-3-(3-hydroxy-5-phenyl-4-isoxazolyl)propionic acid (APPA), which is an analogue of (
RS)-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA), shows the characteristics of a partial AMPA receptor agonist. Since (
S)-APPA is a full AMPA agonist and (
R)-APPA a competitive antagonist, the partial agonism observed for APPA, which is a 1:1 mixture of (
S)- and (
R)-APPA, is only apparent. These observations have prompted comparative pharmacological studies of different molar ratios of a series of AMPA and
N-methyl-
d
-aspartic acid (NMDA) agonists and respective competitive antagonists, and of these agonists in the presence of fixed concentrations of antagonist. Using the rat cortical wedge preparation, the latter series of experiments showed the expected rightward parallel shifts of the dose-response curves. The former type of experiments, on the other hand, produced dose-response curves at different levels of maximal response, depending on the molar ratios of agonist and antagonist used. This phenomenon, which is in agreement with the theory for competitive receptor interaction, has been termed
functional partial agonism, a new pharmacological concept of potential therapeutic utility. These results were obtained using AMPA, the AMPA agonist (
RS)-2-amino-3-(5-
tert-butyl-3-hydroxy-4-isoxazolyl)propionic acid (ATPA), the competitive AMPA antagonists (
RS-2-amino-3-(3-carboxymethoxy-5-methyl-4-isoxazolyl)propionic acid (AMOA) and 6-nitro-7-sulfamoylbenzo[
f] quinoxalin-2,3-dione (NBQX), NMDA, and the competitive NMDA antagonist (
RS)-3-(2-carboxy-4-piperazinyl)propyl-1-phosphonic acid (CPP). Copyright © 1996 Elsevier Science Ltd.</abstract><cop>Oxford</cop><pub>Elsevier Ltd</pub><pmid>8885290</pmid><doi>10.1016/0197-0186(95)00151-4</doi><tpages>8</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0197-0186 |
ispartof | Neurochemistry international, 1996-09, Vol.29 (3), p.309-316 |
issn | 0197-0186 1872-9754 |
language | eng |
recordid | cdi_proquest_miscellaneous_78468358 |
source | ScienceDirect Freedom Collection |
subjects | Alanine - analogs & derivatives Alanine - pharmacology Aminoacid receptors (glycine, glutamate, gaba) Animals Binding, Competitive - drug effects Biological and medical sciences Cell receptors Cell structures and functions Cerebral Cortex - drug effects Cerebral Cortex - metabolism Dinucleoside Phosphates - pharmacology Excitatory Amino Acid Agonists - pharmacology Excitatory Amino Acid Antagonists - pharmacology Fundamental and applied biological sciences. Psychology In Vitro Techniques Isoxazoles - pharmacology Models, Neurological Molecular and cellular biology N-Methylaspartate - pharmacology Propionates - pharmacology Quinoxalines - pharmacology Rats Receptors, AMPA - agonists Receptors, Glutamate - drug effects Receptors, Glutamate - metabolism |
title | FUNCTIONAL PARTIAL AGONISM AT IONOTROPIC EXCITATORY AMINO ACID RECEPTORS |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T09%3A23%3A45IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=FUNCTIONAL%20PARTIAL%20AGONISM%20AT%20IONOTROPIC%20EXCITATORY%20AMINO%20ACID%20RECEPTORS&rft.jtitle=Neurochemistry%20international&rft.au=EBERT,%20BJARKE&rft.date=1996-09-01&rft.volume=29&rft.issue=3&rft.spage=309&rft.epage=316&rft.pages=309-316&rft.issn=0197-0186&rft.eissn=1872-9754&rft.coden=NEUIDS&rft_id=info:doi/10.1016/0197-0186(95)00151-4&rft_dat=%3Cproquest_cross%3E78468358%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c386t-8cb86873ba64ba1b5c5c23cee1adc119bf5a1ce936658700a0f94923b05caf8f3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=78468358&rft_id=info:pmid/8885290&rfr_iscdi=true |